Nucor Corporation (NUE) Balance Sheet

The sequential increase in total assets from $35.6B in Q1 2026 to $37.0B in Q2 2026 is driven primarily by a $300M rise in PPE and a $300M increase in cash, indicating ongoing investment in capacity expansion. Equity growth of $600M quarter-over-quarter, fueled by net income exceeding dividends and buybacks, suggests the balance sheet is strengthening even as the company invests heavily. This trajectory implies that Nucor is using its cyclical upswing to build a larger asset base, which may enhance its competitive position but also increases fixed costs that could pressure returns if demand falters.

The stability in absolute debt levels, despite a $1.0B reduction from Q1 2025's $7.9B, indicates that Nucor is not relying on debt to fund its aggressive capex program. The D/E ratio of 0.31 is consistent with the prior year, suggesting a deliberate policy of maintaining low leverage. This conservative stance may limit refinancing risk, but it also implies that the company is forgoing potential tax shields and leverage benefits, which could be a strategic choice to preserve creditworthiness during cyclical downturns.

The substantial growth in PP&E, from $12.0B in Q2 2024 to $15.9B, reflects the construction of new mills and expansions, which will increase depreciation and fixed costs. Goodwill stability suggests that recent investments are organic, reducing the risk of impairment but increasing the company's exposure to cyclical utilization rates. The rising asset intensity may improve efficiency over the long term, but it also raises the breakeven point, making margins more sensitive to volume fluctuations.

The increase in retained earnings of $3.1B over the past year, despite significant capital returns, indicates that Nucor is retaining a substantial portion of its profits to fund expansion. The equity base is of high quality, driven by operational profitability rather than financial engineering, as evidenced by the absence of large buyback-driven reductions. This suggests that the company's equity is a reliable buffer against cyclical downturns, though the pace of retained earnings growth may slow if margins compress further.

The current ratio of 2.51, though slightly below the 2.90 seen in Q1 2026, remains healthy and above the 2.0 threshold typically considered adequate. Cash of $2.5B, combined with strong operating cash flow, gives Nucor the flexibility to weather a downturn without resorting to debt. However, the sequential decline in the current ratio from 2.90 to 2.51 may indicate that working capital is being absorbed by inventory builds, which could be a leading indicator of margin pressure if demand softens.